Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares reported Q3 net income of $26.8 million, or $1.29 per diluted share, and core net income of $29.0 million, or $1.40 per share; legacy-market loans grew 11.9% annualized, while total loans rose $39.2 million to $5.44 billion. Net interest margin fell 16 basis points to 4.20% as deposit costs increased and deposits declined 2.2% to $6.17 billion; management expects a standalone Q4 margin of 4.25%–4.35%. The company expects its Lincoln Bancorp merger to close in late Q4 2026, bringing pro forma assets to about $9.1 billion, and raised its dividend 22% to $0.22 per share; share repurchases are paused during the transaction process.

Analysis

Core read: The upside case is shifting from acquisition-led scale to organic growth, but the key underwriting variable is deposit quality—not loan demand. Strong production only creates durable earnings if EQBK can fund growth without materially worsening its deposit mix or paying market rates for incremental balances. A higher-rate environment is therefore not unambiguously positive: asset repricing helps, while deposit competition can absorb the benefit, and growth funded at higher marginal cost may lift net interest income while diluting margin.

Relative positioning: If legacy-market loan growth converts to balances and relationship deposits stabilize, EQBK could outperform smaller regional peers whose AOCI constraints limit strategic options. Conversely, higher rates may suppress prospective sellers, reducing the M&A pipeline; acquisition optionality should not be capitalized as near-term earnings. Lincoln adds a separate execution risk: expected accretion depends on closing, conversion and cost-savings delivery, with integration benefits extending into 2027. Pro forma capital also leaves less room to treat another deal as an immediate catalyst.

Timing / disconfirming evidence: Over the next quarter, watch deposit costs and mix, NIM recovery, and whether loan growth is funded by core deposits rather than more expensive funding. Over 6–18 months, test conversion progress, expense leverage and realized organic growth against management’s target. Thesis weakens if deposit attrition persists, NIM misses the guided recovery, credit costs rise beyond the stated run rate, or Lincoln’s close/conversion slips. The transcript contains inconsistent tangible-book-value figures; verify filings before using TBV in valuation work. Without price and valuation context, the signal supports conditional relative positioning, not an unconditional outright long.

Key Decisions for Investors

• Do not chase EQBK solely on production or announced accretion. Consider a modest long EQBK versus a regional-bank ETF only after the next report confirms stable core deposits and NIM recovery; the hedge limits broad rate and regional-bank exposure while expressing a potential organic-growth advantage. Exit or reassess if deposit mix deteriorates further or NIM fails to recover toward guidance.
• Treat Lincoln as a monitored catalyst, not a completed earnings benefit: track regulatory close, conversion milestones, realized cost savings and the gap between pro forma assumptions and reported results. Reduce exposure if closing or second-quarter 2027 conversion timing materially slips.
• Before sizing an outright position, verify current valuation, deposit beta and funding composition, Lincoln’s pro forma balance-sheet details, and the conflicting TBV figures in the transcript versus filings. No reliable price-based risk/reward can be set from the supplied information.